Beam Therapeutics Inc. Common Stock (BEAM) Financials
Key financial figures for Beam Therapeutics Inc. Common Stock (Q1 2026).
- Revenue
- $32M
- Net Income
- -$94M
- EPS
- $-0.91
- Total Assets
- $1.5B
- Operating Cash Flow
- -$129M
Full income statement, balance sheet, and cash flow for Beam Therapeutics Inc. Common Stock on SentiSense.